11/19/2007

Cosmetics companies have taken interest in bimatoprost, an active ingredient in Allergan's glaucoma treatment Lumigan, after some doctors and patients reported eyelash growth as a result of taking the drug. However, federal regulators have begun to scrutinize new cosmetics containing bimatoprost due to potential risks.

Related Summaries